Investor Relations

Corporate Overview

LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in people with presbyopia.

Latest Financial Results

Q3 2024

Quarter Ended Sep 30, 2024

News Icon

Latest News

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Events Icon

Upcoming Event

Jefferies London Healthcare Conference

IR Contacts

Corporate

LENZ Therapeutics, Inc.
201 Lomas Santa Fe Drive
Suite 300
Solana Beach, CA 92075
T: (888) 928-LENZ (5369)
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449

Connect With Us